Glutathiones’ life in multi-cancers: especially their potential micropetides in liver hepatocellular carcinoma
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 18, 2025
Glutathione
plays
critical
roles
in
detoxifying
xenobiotics,
cell
signaling,
death
and
the
antioxidant
defence
an
emerging
body
of
evidence,
most
abundant
intracellular
low
molecular
weight
thiol
tissues.
However,
all
glutathione
metabolism
pertinent
genes
(GMPGs)
expression
their
diagnostic/prognostic/micropeptide
potential
analyses
have
not
been
investigated
to
perform
pan-cancers.
We
gained
GMPGs
from
MsigDB
7.2,
12,123
samples
were
used
reveal
differentially
expressed
(DEGs)
survival
analysis
32
types
cancers
TCGA,
GTEx,
GEO
datasets
for
first
time.
All
statistical
performed
by
R
bioinformatics,
such
as
DEGs,
prognostic,
diagnostic
analysis,
ceRNA,
micropeptide
prediction
immune
infiltration.
In
addition,
we
utilized
siRNA
technology
target
knockdown
G6PD
gene
Huh7
hepatocellular
carcinoma
cells.
was
significantly
poor
prognosis
liver
(LIHC)
predicted
RBM26-AS1
encoded
might
LIHC.
vitro
experiments
show
that
knockout
cells
reduces
proliferation,
migration,
invasion
capabilities.
confirmed
played
a
crucial
role
occurrence
progression
is
positively
associated
with
Th2
LIHC,
regulating
responses
system.
considered
be
new
player
involved
LIHC
interacting
G6PD,
key
function
cancer.
Language: Английский
Effect of Machine Learning on Risk Stratification for Antiretroviral Treatment Failure in People Living with HIV
Infection and Drug Resistance,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 1761 - 1772
Published: April 1, 2025
Despite
the
widespread
use
of
antiretroviral
therapy
(ART),
HIV
virologic
failure
remains
a
significant
global
public
health
challenge.
This
study
aims
to
develop
and
validate
nomogram-based
scoring
system
predict
incidence
determinants
in
people
living
with
(PLWH),
facilitating
timely
interventions
reducing
unnecessary
transitions
second-line
regimens.
A
total
9879
patients
HIV/AIDS
were
included.
The
predictive
model
was
developed
using
training
cohort
(N
=
5,189)
validated
internally
2,228)
externally
2,462)
independent
cohorts.
Multivariable
logistic
regression,
variables
selected
through
least
absolute
shrinkage
selection
operator
(LASSO)
employed.
final
presented
as
nomogram
transformed
into
user-friendly
system.
Key
predictors
included
delayed
ART
initiation
(6
points),
poor
adherence
(7
discontinuation
side
effects
(9
CD4+
T
cell
count
(10
follow-up
safety
index
(FSI)
points).
With
cutoff
15.5
points,
area
under
curve
(AUC)
for
validation
sets
0.807,
0.784,
0.745,
respectively.
demonstrated
robust
diagnostic
performance
across
novel
provides
an
accurate,
well-calibrated
tool
predicting
at
individual
level,
offering
valuable
clinical
utility
optimizing
management.
Language: Английский